NAPRT and cancer: Several compounds have been identified as NAPRT inhibitors, e.g., 2-hydroxinicotinic acid (2-HNA)216 which has been shown to be able to enhance the inhibitory effect of FK866.221 Depending on the type of cancer to be treated, NAPRT may be a predictive biomarker of the NAMPT inhibitors treatment success.